Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

CGF therapy may effectively treat psoriasis by reducing inflammation.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Ixekizumab effectively treats generalized pustular psoriasis.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

A shampoo with cannabidiol can significantly reduce scalp inflammation and symptoms in people with mild to moderate psoriasis or seborrheic dermatitis.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

A new method helps isolate key hair components to study hair growth and loss.

Smart microneedles using advanced tech could improve psoriasis treatment.

Some systemic treatments work for nail psoriasis but can have serious side effects.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.